nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP7—epithelium—ovarian cancer	0.0222	0.0742	CbGeAlD
Doxycycline—MMP7—decidua—ovarian cancer	0.021	0.0701	CbGeAlD
Doxycycline—MMP7—endometrium—ovarian cancer	0.0199	0.0666	CbGeAlD
Doxycycline—MMP1—epithelium—ovarian cancer	0.0196	0.0655	CbGeAlD
Doxycycline—MMP13—vagina—ovarian cancer	0.0187	0.0626	CbGeAlD
Doxycycline—MMP8—female reproductive system—ovarian cancer	0.0187	0.0624	CbGeAlD
Doxycycline—MMP1—decidua—ovarian cancer	0.0185	0.0619	CbGeAlD
Doxycycline—MMP7—uterus—ovarian cancer	0.0183	0.0613	CbGeAlD
Doxycycline—MMP8—bone marrow—ovarian cancer	0.0176	0.0589	CbGeAlD
Doxycycline—MMP7—female reproductive system—ovarian cancer	0.0165	0.0551	CbGeAlD
Doxycycline—MMP1—uterus—ovarian cancer	0.0162	0.0541	CbGeAlD
Doxycycline—MMP7—vagina—ovarian cancer	0.0149	0.0499	CbGeAlD
Doxycycline—MMP1—female reproductive system—ovarian cancer	0.0145	0.0487	CbGeAlD
Doxycycline—Minocycline—CASP3—ovarian cancer	0.0134	0.523	CrCbGaD
Doxycycline—MMP7—testis—ovarian cancer	0.0133	0.0445	CbGeAlD
Doxycycline—MMP1—female gonad—ovarian cancer	0.0132	0.0443	CbGeAlD
Doxycycline—MMP1—vagina—ovarian cancer	0.0132	0.044	CbGeAlD
Doxycycline—MMP8—lymph node—ovarian cancer	0.0109	0.0365	CbGeAlD
Doxycycline—SLC22A11—female reproductive system—ovarian cancer	0.00922	0.0309	CbGeAlD
Doxycycline—Minocycline—VEGFA—ovarian cancer	0.00624	0.243	CrCbGaD
Doxycycline—Minocycline—MMP9—ovarian cancer	0.00603	0.235	CrCbGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP2—ovarian cancer	0.00308	0.00456	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MAPK3—ovarian cancer	0.00306	0.00453	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—ovarian cancer	0.00305	0.00451	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—VEGFA—ovarian cancer	0.00304	0.0045	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—ovarian cancer	0.00303	0.00448	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—ovarian cancer	0.00294	0.00435	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ITGA8—ovarian cancer	0.00294	0.00435	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—IL6ST—ovarian cancer	0.00293	0.00433	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MAPK1—ovarian cancer	0.00291	0.00431	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—ovarian cancer	0.0029	0.00429	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—ovarian cancer	0.00288	0.00426	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—ovarian cancer	0.00288	0.00426	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—ESR1—ovarian cancer	0.0028	0.00415	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—ovarian cancer	0.0028	0.00415	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MYC—ovarian cancer	0.0028	0.00414	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MTOR—ovarian cancer	0.00279	0.00413	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—ovarian cancer	0.00278	0.00412	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN1B—ovarian cancer	0.00276	0.00409	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MAPK1—ovarian cancer	0.00274	0.00405	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—EGFR—ovarian cancer	0.00274	0.00405	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CASP3—ovarian cancer	0.00274	0.00405	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CASP3—ovarian cancer	0.00271	0.00401	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.00265	0.00392	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CDKN1B—ovarian cancer	0.00262	0.00388	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CDH1—ovarian cancer	0.00261	0.00386	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—ovarian cancer	0.00259	0.00383	CbGpPWpGaD
Doxycycline—CYP3A4—female reproductive system—ovarian cancer	0.00258	0.00863	CbGeAlD
Doxycycline—MMP1—Metabolism of proteins—MUC16—ovarian cancer	0.00257	0.00381	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CASP3—ovarian cancer	0.00257	0.0038	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—PTEN—ovarian cancer	0.00254	0.00377	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—CASP3—ovarian cancer	0.00254	0.00376	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CDH1—ovarian cancer	0.00252	0.00373	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP2—ovarian cancer	0.00251	0.00372	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—ovarian cancer	0.00246	0.00364	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—APC—ovarian cancer	0.00245	0.00363	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—SPARC—ovarian cancer	0.00245	0.00363	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—CASP3—ovarian cancer	0.00245	0.00363	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MAPK3—ovarian cancer	0.00244	0.00362	CbGpPWpGaD
Doxycycline—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.00243	0.0036	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP2—ovarian cancer	0.00242	0.00359	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.00242	0.00359	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—ovarian cancer	0.00241	0.00357	CbGpPWpGaD
Doxycycline—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.00241	0.00357	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—ovarian cancer	0.0024	0.00355	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—SPARC—ovarian cancer	0.00237	0.00351	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—CASP3—ovarian cancer	0.00236	0.0035	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MAPK1—ovarian cancer	0.00233	0.00344	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—ovarian cancer	0.00231	0.00343	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—ovarian cancer	0.0023	0.0034	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.00227	0.00336	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—VEGFA—ovarian cancer	0.00221	0.00327	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—CAV1—ovarian cancer	0.00221	0.00327	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—HRAS—ovarian cancer	0.0022	0.00325	CbGpPWpGaD
Doxycycline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00218	0.00323	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—VEGFA—ovarian cancer	0.00218	0.00323	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—STAT3—ovarian cancer	0.00216	0.00319	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—MTOR—ovarian cancer	0.00216	0.00319	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—STAT3—ovarian cancer	0.00213	0.00316	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MYC—ovarian cancer	0.00211	0.00313	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—RAD51C—ovarian cancer	0.00211	0.00312	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MAPK3—ovarian cancer	0.00206	0.00305	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—STAT3—ovarian cancer	0.00206	0.00305	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.00205	0.00304	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MAPK3—ovarian cancer	0.00204	0.00301	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CDKN1B—ovarian cancer	0.00202	0.00299	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CDH1—ovarian cancer	0.00201	0.00298	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CASP3—ovarian cancer	0.002	0.00296	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CASP3—ovarian cancer	0.00198	0.00294	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—ovarian cancer	0.00198	0.00293	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MAPK3—ovarian cancer	0.00197	0.00291	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MAPK1—ovarian cancer	0.00196	0.0029	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.00195	0.00289	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—ovarian cancer	0.00194	0.00287	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—ovarian cancer	0.00194	0.00287	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MAPK1—ovarian cancer	0.00194	0.00287	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—EGFR—ovarian cancer	0.00194	0.00287	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CASP3—ovarian cancer	0.00193	0.00286	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—ovarian cancer	0.00191	0.00283	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.00191	0.00282	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TERT—ovarian cancer	0.00189	0.0028	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—SPARC—ovarian cancer	0.00189	0.0028	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—ovarian cancer	0.00189	0.00279	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MAPK1—ovarian cancer	0.00187	0.00277	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—EGFR—ovarian cancer	0.00187	0.00277	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL2—ovarian cancer	0.00187	0.00276	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—KRAS—ovarian cancer	0.00185	0.00274	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—ovarian cancer	0.00183	0.0027	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—ovarian cancer	0.00182	0.0027	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCND1—ovarian cancer	0.00182	0.00269	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.0018	0.00267	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—ovarian cancer	0.00177	0.00261	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—PTEN—ovarian cancer	0.00176	0.0026	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CAV1—ovarian cancer	0.00175	0.00259	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—ovarian cancer	0.00174	0.00257	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CXCL8—ovarian cancer	0.00172	0.00255	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MET—ovarian cancer	0.0017	0.00251	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CCND1—ovarian cancer	0.00168	0.00249	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—ovarian cancer	0.00168	0.00249	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CTNNB1—ovarian cancer	0.00167	0.00247	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—STAT3—ovarian cancer	0.00167	0.00247	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—INHA—ovarian cancer	0.00166	0.00246	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—ovarian cancer	0.00165	0.00244	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL2—ovarian cancer	0.00164	0.00243	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—MAPK3—ovarian cancer	0.00163	0.00242	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—MAPK3—ovarian cancer	0.00159	0.00236	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—HRAS—ovarian cancer	0.00157	0.00233	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—PIK3CA—ovarian cancer	0.00157	0.00232	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—MAPK1—ovarian cancer	0.00155	0.0023	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CASP3—ovarian cancer	0.00154	0.00228	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—PIK3CB—ovarian cancer	0.00154	0.00228	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.00152	0.00224	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—ovarian cancer	0.00152	0.00224	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—MAPK1—ovarian cancer	0.00151	0.00224	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CDH1—ovarian cancer	0.0015	0.00222	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—AKT1—ovarian cancer	0.00147	0.00217	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MYC—ovarian cancer	0.00146	0.00216	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—ovarian cancer	0.00146	0.00216	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—ovarian cancer	0.00144	0.00214	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—KRAS—ovarian cancer	0.00143	0.00212	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—AKT1—ovarian cancer	0.00141	0.00208	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—AKT1—ovarian cancer	0.00139	0.00206	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.00138	0.00205	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—AKT1—ovarian cancer	0.00137	0.00203	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—MYC—ovarian cancer	0.00135	0.002	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—AKT1—ovarian cancer	0.00133	0.00196	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	0.00132	0.00196	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.00132	0.00195	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—AKT1—ovarian cancer	0.00128	0.0019	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—ovarian cancer	0.00127	0.00188	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	0.00126	0.00186	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—HRAS—ovarian cancer	0.00125	0.00185	CbGpPWpGaD
Doxycycline—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00122	0.00181	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—HRAS—ovarian cancer	0.00122	0.0018	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—ovarian cancer	0.0012	0.00177	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.00119	0.00177	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—NRAS—ovarian cancer	0.00119	0.00176	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—TUBB3—ovarian cancer	0.00117	0.00173	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CASP3—ovarian cancer	0.00115	0.0017	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SPARC—ovarian cancer	0.00113	0.00167	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—ovarian cancer	0.00111	0.00164	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—AKT1—ovarian cancer	0.0011	0.00163	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.0011	0.00163	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL6—ovarian cancer	0.0011	0.00162	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CCND1—ovarian cancer	0.00109	0.00162	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CDH1—ovarian cancer	0.00109	0.00162	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—ovarian cancer	0.00108	0.0016	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—AKT1—ovarian cancer	0.00107	0.00159	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	0.00106	0.00156	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CDH1—ovarian cancer	0.00106	0.00156	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—ovarian cancer	0.00105	0.00156	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.00102	0.00151	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—ovarian cancer	0.00102	0.0015	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.00101	0.0015	CbGpPWpGaD
Doxycycline—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.001	0.00149	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000994	0.00147	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000989	0.00146	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ATF3—ovarian cancer	0.000986	0.00146	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000983	0.00146	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000974	0.00144	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	0.000966	0.00143	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000955	0.00141	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000953	0.00141	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000949	0.0014	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.000938	0.00139	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	0.000891	0.00132	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MYC—ovarian cancer	0.000878	0.0013	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.000868	0.00129	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MAPK1—ovarian cancer	0.000859	0.00127	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000857	0.00127	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CDH1—ovarian cancer	0.000844	0.00125	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CASP3—ovarian cancer	0.000837	0.00124	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SOD1—ovarian cancer	0.000818	0.00121	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PPP2R1A—ovarian cancer	0.000814	0.0012	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—ovarian cancer	0.000812	0.0012	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CASP3—ovarian cancer	0.000808	0.0012	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—ovarian cancer	0.000791	0.00117	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000789	0.00117	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000771	0.00114	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000771	0.00114	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—ovarian cancer	0.000764	0.00113	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000758	0.00112	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000754	0.00112	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000753	0.00111	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000729	0.00108	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000728	0.00108	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000726	0.00108	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—ovarian cancer	0.000721	0.00107	CbGpPWpGaD
Doxycycline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00072	0.00107	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000685	0.00101	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000654	0.000968	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000648	0.000959	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CASP3—ovarian cancer	0.000646	0.000956	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000632	0.000936	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000629	0.000932	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—ovarian cancer	0.00061	0.000904	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—AKT1—ovarian cancer	0.000609	0.000902	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000608	0.0009	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000606	0.000898	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CAV1—ovarian cancer	0.000598	0.000885	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000574	0.00085	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000547	0.00081	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CG—ovarian cancer	0.000545	0.000806	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000528	0.000782	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000521	0.000772	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000502	0.000744	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000485	0.000718	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000479	0.00071	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CD—ovarian cancer	0.000479	0.000709	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000428	0.000634	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CB—ovarian cancer	0.000417	0.000618	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IL2—ovarian cancer	0.000383	0.000568	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000383	0.000567	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000383	0.000567	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—ovarian cancer	0.00038	0.000562	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00037	0.000548	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—ovarian cancer	0.000326	0.000482	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NRAS—ovarian cancer	0.000322	0.000476	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00032	0.000473	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CXCL8—ovarian cancer	0.000316	0.000467	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000309	0.000457	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—MAPK3—ovarian cancer	0.000308	0.000456	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—MAPK1—ovarian cancer	0.000293	0.000434	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000292	0.000433	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CTNNB1—ovarian cancer	0.000291	0.000431	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—KRAS—ovarian cancer	0.000277	0.00041	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CA—ovarian cancer	0.000254	0.000377	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—ovarian cancer	0.000246	0.000364	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000244	0.000361	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—HRAS—ovarian cancer	0.000235	0.000349	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000228	0.000337	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000224	0.000332	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—AKT1—ovarian cancer	0.000208	0.000308	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NME2—ovarian cancer	0.000139	0.000205	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYTB—ovarian cancer	8.94e-05	0.000132	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.81e-05	0.000116	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.81e-05	0.000116	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—YAP1—ovarian cancer	5.24e-05	7.76e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—FASN—ovarian cancer	4.27e-05	6.33e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.2e-05	6.22e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.06e-05	6.01e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.89e-05	5.76e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.45e-05	5.11e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.2e-05	4.74e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMS—ovarian cancer	3.15e-05	4.66e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CAV1—ovarian cancer	2.54e-05	3.76e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.31e-05	3.42e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.03e-05	3.01e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.77e-05	2.62e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTEN—ovarian cancer	1.53e-05	2.26e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.08e-05	1.6e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AKT1—ovarian cancer	8.81e-06	1.31e-05	CbGpPWpGaD
